Your trusted destination for CME, CPD & Medical Education across the Middle East.
Quant Biomarkers AG
Dr. Sanja Tomovska is a pharmaceutical executive, scientist, and biotechnology entrepreneur with more than 20 years of experience across the pharmaceutical, biotechnology, and diagnostics industries. Based in Switzerland, she is the Founder and CEO of Quant Biomarkers AG, a precision diagnostics company focused on developing biomarker-based solutions for earlier disease detection, risk assessment, and personalised healthcare.
Dr. Tomovska holds a PhD in Molecular Biology from the University of Basel, Switzerland, specialising in cancer research and biomarkers in cancer diagnostics. Her scientific background is complemented by executive business education at INSEAD and additional business studies at Columbia Business School. Her early research focused on molecular and genetic changes associated with tumour development and progression, including published work on urinary bladder cancer.
Throughout her pharmaceutical career, Dr. Tomovska has held strategic and leadership responsibilities at major international companies, including Novartis, Roche, and Abbott. Her experience spans research and development, clinical and medical affairs, pharmaceutical portfolio strategy, mergers and acquisitions, product lifecycle management, commercialisation, and market access. She has also been involved in business transformation initiatives and the development of strategies to expand access to innovative medicines across international markets.
As CEO of Quant Biomarkers, Dr. Tomovska leads the company's development of precision diagnostic technologies, including biomarker panels designed to support earlier detection and better understanding of chronic diseases. The company's work includes kidney-health diagnostics and risk assessment for cardio-kidney-metabolic conditions. She is also involved in the longevity and preventive-health sector through her role as Co-founder and General Manager of Humansa Suisse, contributing to initiatives that connect scientific innovation with personalised health and longevity services.

dmg events
dmg events